Stoppelman Jeremy 4
4 · YELP INC · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Yelp CEO Jeremy Stoppelman Exercises Options, Sells 66,200 Shares
What Happened
- Jeremy Stoppelman, CEO of Yelp (YELP), exercised stock options totaling 66,200 shares at an exercise price of $20.47 per share and sold those same 66,200 shares in open-market transactions. He paid $1,355,114 to exercise the options and received aggregate sale proceeds of $1,678,961.
- In addition, the filing shows awards of restricted stock units (RSUs): 152,573 RSUs that vest quarterly over four years (F1) and 55,796 performance-based RSUs that became eligible to vest based on achieved goals (F2) — together 208,369 award shares granted/acquired at $0.00 in the report.
Key Details
- Transaction dates: exercises and sales occurred Feb 3–5, 2026; filing date: Feb 5, 2026 (Form 4 filed timely).
- Exercise details: 30,000 shares on Feb 3, 30,000 on Feb 4, and 6,200 on Feb 5 at $20.47 each (total exercise cost $1,355,114).
- Sales (open market): matched the exercised shares — 30,000 sold on Feb 3 (weighted avg prices reported), 30,000 on Feb 4, and 6,200 on Feb 5 — total proceeds $1,678,961. The filing reports weighted-average sale prices and price ranges for the multiple trades (see F4–F8).
- Awards: 152,573 RSUs vesting quarterly over four years (F1); 55,796 performance-based RSUs became eligible to vest on Feb 20, 2026 subject to continued service (F2).
- Sales executed pursuant to a pre-established 10b5-1 trading plan (F3).
- Shares owned after the reported transactions: not specified in the Form 4 summary provided.
Context
- This was effectively a cashless exercise: Stoppelman exercised options and sold the same shares immediately (exercise price paid and shares sold in the market).
- RSU awards are granted at $0.00 but are subject to vesting and service/performance conditions and thus do not represent immediately liquid shares.
- These are routine insider transactions (compensation-related exercises and planned sales under a 10b5-1 plan); the filing is factual and does not indicate insider sentiment.
Insider Transaction Report
Form 4
YELP INCYELP
Stoppelman Jeremy
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-02-03+152,573→ 909,031 total - Award
Common Stock
[F2]2026-02-03+55,796→ 964,827 total - Exercise/Conversion
Common Stock
2026-02-03$20.47/sh+30,000$614,100→ 994,827 total - Sale
Common Stock
[F3][F4]2026-02-03$25.68/sh−14,269$366,408→ 980,558 total - Sale
Common Stock
[F3][F5]2026-02-03$26.63/sh−15,731$418,921→ 964,827 total - Exercise/Conversion
Common Stock
2026-02-04$20.47/sh+30,000$614,100→ 994,827 total - Sale
Common Stock
[F3][F6]2026-02-04$24.78/sh−29,400$728,394→ 965,427 total - Sale
Common Stock
[F3][F7]2026-02-04$25.37/sh−600$15,222→ 964,827 total - Exercise/Conversion
Common Stock
2026-02-05$20.47/sh+6,200$126,914→ 971,027 total - Sale
Common Stock
[F3][F8]2026-02-05$24.20/sh−6,200$150,016→ 964,827 total - Exercise/Conversion
Stock Option (Right to Buy)
[F9]2026-02-03$20.47/sh−30,000$614,100→ 36,200 totalExercise: $20.47Exp: 2026-03-09→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F9]2026-02-04$20.47/sh−30,000$614,100→ 6,200 totalExercise: $20.47Exp: 2026-03-09→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F9]2026-02-05$20.47/sh−6,200$126,914→ 0 totalExercise: $20.47Exp: 2026-03-09→ Common Stock (6,200 underlying)
Footnotes (9)
- [F1]Represents the grant of restricted stock units that vest in equal quarterly installments over four years from the date of grant.
- [F2]On January 25, 2023, the Reporting Person was granted performance-based restricted stock units covering 70,834 shares of the Issuer's common stock at the target performance level, zero to 200% of which would become eligible to vest based on the achievement of performance goals. On February 3, 2026, the performance criteria were met, resulting in 55,796 shares becoming eligible to vest on February 20, 2026, subject to the Reporting Person's continued service with the Issuer.
- [F3]Shares were sold pursuant to a duly adopted 10b5-1 trading plan, adopted by the reporting person on May 19, 2025.
- [F4]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $25.35 to $26.28, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
- [F5]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $26.38 to $27.035, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
- [F6]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $24.31 to $25.29, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
- [F7]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $25.34 to $25.40, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
- [F8]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $23.98 to $24.46, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
- [F9]Fully vested.
Signature
/s/ Elizabeth Prosser, Attorney-in-Fact|2026-02-05